ACS Omega
(Jan 2024)
Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma
- Perpetue Bataille Backer,
- Tayo Alex Adekiya,
- Yushin Kim,
- Terry-Elinor R. Reid,
- Michael Thomas,
- Simeon K. Adesina
Affiliations
- Perpetue Bataille Backer
- Department of Pharmaceutical Sciences, Howard University, Washington D.C., United States
- Tayo Alex Adekiya
- Department of Pharmaceutical Sciences, Howard University, Washington D.C., United States
- Yushin Kim
- Department of Pharmaceutical Sciences, Concordia University of Wisconsin, Mequon, Wisconsin, United States
- Terry-Elinor R. Reid
- Department of Pharmaceutical Sciences, Concordia University of Wisconsin, Mequon, Wisconsin, United States
- Michael Thomas
- Department of Biology, Howard University, Washington D.C., United States
- Simeon K. Adesina
- Department of Pharmaceutical Sciences, Howard University, Washington D.C., United States
- DOI
-
https://doi.org/10.1021/acsomega.3c07486
- Journal volume & issue
-
Vol. 9,
no. 2
pp.
2615
– 2628
WeChat QR code